Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Deborah M. AutorDirector | Amneal PharmaceuticalsAMRX | Open-market sale | 05/11 | 05/12 | 34,819 sh | $12.94 | $450,557.86 | −27.1% |
Ted C. NarkDirector | Amneal PharmaceuticalsAMRX | Open-market sale | 25/11/17 | 25/11/19 | 50,000 sh | $11.72 | $586,000 | −14.7% |
Nikita ShahEVP | Amneal PharmaceuticalsAMRX | Open-market sale | 25/11/12 | 25/11/14 | 131,856 sh | $11.92 | $1,571,723.52 | −47.4% |
John KielyDirector | Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/27 | 25/08/28 | 32,000 sh | $9.23 | $295,360 | −12.4% |
EVP | Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/22–25/08/25 | 25/08/25 | 120,832 sh2 trades | $9.65avg. | $1,166,222.72 | −45.2% |
Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/20 | 25/08/22 | 279,244 sh | $9.38 | $2,619,308.72 | −64.7% | |
Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/13–25/08/15 | 25/08/15 | 499,730 sh3 trades | $9.33avg. | $4,663,070.47 | −80.4% | |
Nikita ShahEVP | Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/14 | 25/08/15 | 71,694 sh | $9.29 | $666,037.26 | −21.2% |
Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/12 | 25/08/13 | 33,436 sh | $9.05 | $302,595.8 | −11.5% | |
Nikita ShahEVP | Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/12 | 25/08/13 | 50,000 sh | $9.04 | $452,000 | −12.9% |
Daly Jason B.EVP, Chief Legal Officer | Amneal PharmaceuticalsAMRX | Open-market sale | 25/08/12 | 25/08/13 | 22,000 sh | $9.05 | $199,100 | −67.5% |
Gautam PatelDirector | Amneal PharmaceuticalsAMRX | Open-market sale10b5-1 plan | 25/06/16 | 25/06/18 | 94,906 sh | $8.02 | $761,146.12 | −5.6% |
Gautam PatelDirector | Amneal PharmaceuticalsAMRX | Open-market sale | 25/06/10 | 25/06/12 | 56,426 sh | $8.02 | $452,536.52 | −3.2% |
Nikita ShahEVP | Amneal PharmaceuticalsAMRX | Open-market sale | 25/05/16 | 25/05/19 | 49,140 sh | $7.58 | $372,481.2 | −11.2% |
John KielyDirector | Amneal PharmaceuticalsAMRX | Open-market sale | 25/05/12 | 25/05/13 | 50,000 sh | $7.59 | $379,500 | −16.3% |
Amneal PharmaceuticalsAMRX | Open-market sale | 25/05/02–25/05/05 | 25/05/06 | 8,668 sh2 trades | $8.00avg. | $69,344 | −0.5% | |
Gautam PatelDirector | Amneal PharmaceuticalsAMRX | Open-market sale | 25/04/01 | 25/04/02 | 80,000 sh | $8.30 | $664,000 | −4.4% |
Tushar Bhikhubhai Patel10% Owner | Amneal PharmaceuticalsAMRX | Open-market sale | 25/03/14 | 25/03/17 | 5,000,000 sh | $8.35 | $41,750,000 | −9.3% |
EVP, Chief Legal Officer | Amneal PharmaceuticalsAMRX | Open-market sale | 25/03/05–25/03/06 | 25/03/07 | 90,000 sh2 trades | $8.80avg. | $792,159.6 | −73.4% |
Amneal PharmaceuticalsAMRX | Open-market sale | 25/03/05 | 25/03/07 | 125,000 sh | $8.89 | $1,111,250 | −30.1% |
